Oregon 2025R1 Session Status: Enacted

SB 289 — Modifies, from quarterly to annually, the timing of the Department of Consumer and Business Services' requirement to report certain information to the Prescription Drug Affordability Board.

Last action — Chapter Number Assigned

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced June 06, 2025. Enacted.

Prognosis

Likely to advance 68% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • Cleared a recorded vote

    Passed 4 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

<b>Digest: This Act changes the time of the report about some information from DCBS to PDAB to yearly. Changes the number of drugs PDAB must identify for cost issues. Changes PDAB's reporting about generic drugs. (Flesch Readability Score: 60.9).</b> [<i>Digest: The Act makes the State Board of Pharmacy study prescription drugs. (Flesch Readability Score: 72.6).</i>] [<i>Requires the State Board of Pharmacy to study prescription drugs. Directs the board to submit findings to the interim committees of Legislative Assembly related to health care not later than September 15, 2026.</i>] [<i>Sunsets on January 2, 2027.</i>] <b>Modifies, from quarterly to annually, the timing of the Department of Consumer and Business Services' requirement to report certain information to the Prescription Drug Affordability Board. Modifies the number of prescription drugs that may create affordability challenges that the board is directed to identify. Modifies the board's reporting requirements for the status of the generic drug market.</b>

Bill Text

We don't have the full text on file for this bill yet.

Read SB 289 on the official Oregon source →

Action History

  1. Chapter Number Assigned

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 90 not signed on · 1 voted No

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (90)

90 members have not signed on to this bill.

Show all 90 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Third reading. Carried by Munoz. Passed.

Passed 49 Yea · 1 Nay · 9 Other
Party YeaNayPresentNot Voting
Democrat 28002
Republican 16105
Unaffiliated 5002
Total 49109
% of votes cast 83%2%0%15%
How each member voted (59)
Member Party Vote
Rep Levy E — Yea
Rep Nguyen H — Not Voting
Rep Smith G — Not Voting
Rep Levy B — Yea
Rep Nguyen D — Yea
Rep Pham H — Yea
Rep Munoz — Yea
Andrea Valderrama Democrat Yea
Annessa Hartman Democrat Yea
April Dobson Democrat Yea
Ben Bowman Democrat Yea
Dacia Grayber Democrat Yea
David Gomberg Democrat Yea
Farrah Chaichi Democrat Not Voting
Jason Kropf Democrat Yea
John Lively Democrat Yea
Jules Walters Democrat Yea
Julie Fahey Democrat Yea
Ken Helm Democrat Yea
Lisa Fragala Democrat Not Voting
Mari Watanabe Democrat Yea
Mark Gamba Democrat Yea
Nancy Nathanson Democrat Yea
Nathan Sosa Democrat Yea
Pam Marsh Democrat Yea
Paul Evans Democrat Yea
Ricki Ruiz Democrat Yea
Rob Nosse Democrat Yea
Sarah McDonald Democrat Yea
Shannon Isadore Democrat Yea
Susan McLain Democrat Yea
Tawna Sanchez Democrat Yea
Thuy Tran Democrat Yea
Tom Andersen Democrat Yea
Travis Nelson Democrat Yea
Willy Chotzen Democrat Yea
Zach Hudson Democrat Yea
Alek Skarlatos Republican Yea
Anna Scharf Republican Yea
Boomer Wright Republican Not Voting
Christine Drazan Republican Yea
Court Boice Republican Yea
Cyrus Javadi Republican Yea
Darcey Edwards Republican Not Voting
Darin Harbick Republican Yea
Dwayne Yunker Republican Not Voting
E. Werner Reschke Republican Yea
Ed Diehl Republican Yea
Emily McIntire Republican Yea
Jami Cate Republican Nay
Jeffrey Helfrich Republican Yea
Kevin Mannix Republican Yea
Kim Wallan Republican Not Voting
Lucetta Elmer Republican Yea
Mark Owens Republican Not Voting
Rick Lewis Republican Yea
Shelly Boshart Davis Republican Yea
Vikki Breese-Iverson Republican Yea
Virgle Osborne Republican Yea

Official roll call →

Third reading. Carried by Patterson. Passed.

Passed 29 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 16000
Republican 11000
Unaffiliated 2001
Total 29001
% of votes cast 97%0%0%3%
How each member voted (30)
Member Party Vote
Sen Smith DB — Yea
Sen Woods — Not Voting
Sen Pham — Yea
Anthony Broadman Democrat Yea
Chris Gorsek Democrat Yea
Deb Patterson Democrat Yea
Floyd Prozanski Democrat Yea
James Manning Jr. Democrat Yea
Janeen Sollman Democrat Yea
Jeff Golden Democrat Yea
Kate Lieber Democrat Yea
Kathleen Taylor Democrat Yea
Kayse Jama Democrat Yea
Lew Frederick Democrat Yea
Lisa Reynolds Democrat Yea
Mark Meek Democrat Yea
Rob Wagner Democrat Yea
Sara Gelser Blouin Democrat Yea
Wlnsvey Campos Democrat Yea
Bruce Starr Republican Yea
Cedric Hayden Republican Yea
Daniel Bonham Republican Yea
Diane Linthicum Republican Yea
Dick Anderson Republican Yea
Fred Girod Republican Yea
Kim Thatcher Republican Yea
Mike McLane Republican Yea
Noah Robinson Republican Yea
Suzanne Weber Republican Yea
Todd Nash Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 289 do?
<b>Digest: This Act changes the time of the report about some information from DCBS to PDAB to yearly. Changes the number of drugs PDAB must identify for cost issues. Changes PDAB's reporting about generic drugs. (Flesch Readability Score: 60.9).</b> [<i>Digest: The Act makes the State Board of Pharmacy study prescription drugs. (Flesch Readability Score: 72.6).</i>] [<i>Requires the State Board of Pharmacy to study prescription drugs. Directs the board to submit findings to the interim committees of Legislative Assembly related to health care not later than September 15, 2026.</i>] [<i>Sunsets on January 2, 2027.</i>] <b>Modifies, from quarterly to annually, the timing of the Department of Consumer and Business Services' requirement to report certain information to the Prescription Drug Affordability Board. Modifies the number of prescription drugs that may create affordability challenges that the board is directed to identify. Modifies the board's reporting requirements for the status of the generic drug market.</b>
What is the current status of SB 289?
This bill has been enacted into law. Introduced June 06, 2025. Enacted.
Where can I track SB 289?
Track SB 289 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 289

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 289

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →